Publications by authors named "Suzanne P Linn-Rasker"

Claim this Profile
T
Tocilizumab vs prednisone in established rheumatoid arthritis patients (TOPIRA): an investigator-initiated randomised clinical trial.
Sina Fadaei, Matthijs S van der Leeuw, Suzanne P Linn-Rasker, Bo de Klerk, Judith J W Peeters

Rheumatology (Oxford)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular risk in patients with new gout: should we reclassify the risk?
Mihaela Gamala, Johannes W G Jacobs, Suzanne P Linn-Rasker, Maarten Nix, Ben G F Heggelman

Clin Exp Rheumatol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular risk in patients with new gout diagnosis: is monosodium urate volume at ankles and feet on dual-energy computed tomography associated with previous cardiovascular events?
Mihaela Gamala, Johannes W G Jacobs, Suzanne P Linn-Rasker, Maarten Nix, Ben G F Heggelman

Clin Exp Rheumatol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of TOcilizumab in comparison to Prednisone In Rheumatoid Arthritis patients with insufficient response to disease-modifying antirheumatic drugs (TOPIRA): study protocol for a pragmatic trial.
Matthijs S van der Leeuw, Paco M J Welsing, Maria J H de Hair, Johannes W G Jacobs, Anne C A Marijnissen, Suzanne P Linn-Rasker

Trials· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initiating tocilizumab, with or without methotrexate, compared with starting methotrexate with prednisone within step-up treatment strategies in early rheumatoid arthritis: an indirect comparison of effectiveness and safety of the U-Act-Early and CAMERA-II treat-to-target trials.
Maxime Ma Verhoeven, Marjolein Jh de Hair, Janneke Tekstra, Johannes Wj Bijlsma, Jacob M van Laar, Suzanne P Linn-Rasker

Ann Rheum Dis· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RNA sequencing to predict response to TNF-α inhibitors reveals possible mechanism for nonresponse in smokers.
Bart V J Cuppen, Marzia Rossato, Ruth D E Fritsch-Stork, Arno N Concepcion, Suzanne P Linn-Rasker

Expert Rev Clin Immunol· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Do radiographic joint damage and disease activity influence functional disability through different mechanisms? Direct and indirect effects of disease activity in established rheumatoid arthritis.
Sandhya C Nair, Johannes W J Bijlsma, Jacobien H van der Werf, Maaike J van der Veen, Suzanne P Linn-Rasker

J Rheumatol· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Merkel cell carcinoma during treatment with TNF-alpha inhibitors: coincidence or warning?].
Suzanne P Linn-Rasker, G A van Albada-Kuipers, Stefan V Dubois, Karlijn Janssen, Petra G M A Zweers

Ned Tijdschr Geneeskd· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The starting dose of levothyroxine in primary hypothyroidism treatment: a prospective, randomized, double-blind trial.
Annemieke Roos, Suzanne P Linn-Rasker, Ron T van Domburg, Jan P Tijssen, Arie Berghout

Arch Intern Med· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis